INS and metabolic dysfunction-associated steatotic liver disease: The main signaling pathways involved include the HIF-1 pathway, AMPK pathway, insulin resistance pathway thyroid hormone pathway, etc. It has been found through experiments that SYTZD can improve lipid deposition, insulin resistance, and inflammation to play a role in the treatment of NAFLD.